Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0756
D

Failure to Implement Pharmacist's Medication Safety Recommendation

Kansas City, Kansas Survey Completed on 08-12-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to act upon the Consultant Pharmacist's recommendation to add 'do not crush' instructions to a resident's Dulcolax delayed release (DR) medication order. The resident in question had diagnoses of major depressive disorder, Alzheimer's disease, and a history of cerebrovascular accident, with severely impaired cognition and significant assistance required for activities of daily living. The resident's care area assessment indicated a risk of adverse side effects from medications, and the care plan directed nursing staff to administer medications as ordered by the physician. However, the medication order for Dulcolax DR did not include 'do not crush' instructions, despite the pharmacist's recommendation documented in the monthly medication review. Review of the resident's medication administration record for the relevant month confirmed the absence of the 'do not crush' directive for Dulcolax. Interviews with administrative nursing staff revealed an expectation that pharmacy recommendations would be reviewed and acted upon within seven days, but this was not done in this case. The facility's policy required that drug regimen reviews be conducted monthly by a licensed pharmacist, with any identified irregularities reported to the attending physician, medical director, and director of nursing services for action. The failure to implement the pharmacist's recommendation resulted in a deficiency related to the management of the resident's medication regimen.

An unhandled error has occurred. Reload 🗙